RVTY logo

REVVITY INC

RVTYNYSE
πŸ† #634 by market capUS Equity
$152.77β–² $1.76 (+1.15%)
After hours Β· at close
πŸ””
Track RVTY
Get earnings, price moves & breaking news on Telegram
Track
24hβ–² 1.1%
7dβ–² 6.6%
14dβ–² 9.0%
30dβ–² 18.6%
ytdβ–² 57.8%
1yβ–² 81.2%
🏦Market Cap
$17.04B
Mid Cap
πŸ“ˆRevenue Growth (YoY)
+4.0%
Slowing
πŸ“ŠGross Margin
55.0%
Healthy
πŸ’΅FCF Margin
19.2%
Healthy
βš–οΈP/S Ratio
5.7x
Fair
Otter Score
76
Good

Trading Snapshot

Day Range
$151.06 – $153.99
52-Week Range
$81.22 – $152.26
Volume
$1.71B
Avg Volume
$1.72B
Shares Outstanding
111.6M
Next Earnings
Nov 30, 2026

Fundamentals Snapshot

Annual Revenue
$2.86B
Last Q Revenue
$730M
P/E Ratio
70.3
P/S Ratio
5.7x
EPS (TTM)
$2.10
Dividend Yield
0.19%
Dilution (1yr)
βˆ’6.9%

Why Investors Own RVTY

  • βœ“High-growth profile β€” revenue up +8.9% YoY with expanding US Equity exposure.
  • βœ“Healthy economics β€” 49% gross margin and 18% free-cash-flow margin.
  • βœ“New products and segments could unlock additional revenue streams.
⚠️ Key Risks

Execution delays, intensifying competition, and valuation compression if growth decelerates.

RVTY logo

REVVITY INC

RVTY
Financial Trends
RevenueThe total money the company brought in from sales, before subtracting any costs.
$2.9Bβ–² +3.7% YoY
Gross MarginOf every $1 of sales, how much is left after the direct cost of making the product/service. Higher = more efficient.
53.1%β–² +10.6% YoY
Operating IncomeProfit from the core business after operating costs, but before interest and taxes. Negative means the core business isn’t profitable yet.
$357Mβ–Ό βˆ’13.1% YoY
Free Cash FlowCash left over after running the business and paying for equipment/capex. Negative means the company is burning cash.
$508Mβ–Ό βˆ’6.2% YoY
Shares OutstandingHow many shares exist. Rising means the company is issuing more shares, which dilutes (shrinks) each existing owner’s slice.
113.2Mβ–Ό βˆ’6.9% YoY
Net CashCash minus total debt. Positive = more cash than debt (financially strong); negative = more debt than cash (net debt).
βˆ’$2.6Bβ–Ό βˆ’$434M YoY
StockOtter Β· stockotter.space

About REVVITY INC

Revvity, Inc., founded in 1937 and based in Waltham, Massachusetts, is a global enterprise that develops and delivers a wide array of products, services, and solutions. The company, which changed its name from PerkinElmer, Inc. in April 2023, caters to the diagnostics, life sciences, and applied services sectors worldwide. Its Discovery & Analytical Solutions division provides advanced instrumentation, reagents, informatics, software, subscriptions, and sophisticated detection and imaging technologies. These resources are designed to enable scientists to achieve significant breakthroughs in life sciences research. This segment also offers contract research and specialized laboratory services. Furthermore, it supplies analytical tools and services for assessing environmental health, including air, water, and soil, and delivers solutions to agricultural and food producers. It also serves the industrial market with analytical instrumentation for sectors such as chemical, semiconductor, electronics, energy, lubricants, petrochemicals, and polymers. The Diagnostics segment is dedicated to early detection, offering instruments, reagents, assay platforms, and software for identifying genetic disorders in pregnant individuals and young children, alongside infectious disease testing. Its products facilitate the screening of genetic abnormalities, disorders, and diseases like Down syndrome, hypothyroidism, muscular dystrophy, infertility, and various metabolic conditions. This division also innovates technologies that support genomic workflows, leveraging protein-coupled receptor and next-generation DNA sequencing for applications in oncology, immunodiagnostics, and drug discovery. Revvity serves a diverse clientele, including pharmaceutical and biotechnology firms, laboratories, academic and research institutions, public health authorities, private healthcare organizations, medical professionals, and government bodies.

🦦

Otter Score Breakdown

How it's scoredFive components, each rated 1–5β˜… and equally weighted (20%), averaged to a 0–100 score:πŸ’Ž Quality β€” gross marginπŸš€ Growth β€” revenue YoYβš–οΈ Valuation β€” P/S ratio⚑ Momentum β€” 30-day price changeπŸ’§ Dilution β€” 1-yr share issuance (buybacks score higher)
πŸ’ŽQualityβ˜…β˜…β˜…β˜…β˜…
πŸš€Growthβ˜…β˜…β˜…β˜…β˜…
βš–οΈValuationβ˜…β˜…β˜…β˜…β˜…
⚑Momentumβ˜…β˜…β˜…β˜…β˜…
πŸ’§Dilutionβ˜…β˜…β˜…β˜…β˜…
Overall Score
Good
76/100

Analyst Price Target

β“˜
Average Target
$164.53
β–² +7.7% Upside
High Target$181.27
Low Target$130.00
Based on 36 analysts

Latest News & Updates